Cancer of unknown primary site
N Pavlidis, G Pentheroudakis - The Lancet, 2012 - thelancet.com
Cancer of unknown primary site (CUP) is a well recognised clinical disorder, accounting for
3–5% of all malignant epithelial tumours. CUP is clinically characterised as an aggressive …
3–5% of all malignant epithelial tumours. CUP is clinically characterised as an aggressive …
Cancer of unknown primary
MS Lee, HK Sanoff - Bmj, 2020 - bmj.com
Cancers of unknown primary (CUPs) are histologically confirmed, metastatic malignancies
with a primary tumor site that is unidentifiable on the basis of standard evaluation and …
with a primary tumor site that is unidentifiable on the basis of standard evaluation and …
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
A Krämer, T Bochtler, C Pauli, G Baciarello… - Annals of …, 2023 - annalsofoncology.org
CUP accounts for< 5% of cancers but, because of its high mortality rate, its relative
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
K Fizazi, FA Greco, N Pavlidis, G Daugaard… - Annals of …, 2015 - annalsofoncology.org
Cancers of unknown primary site (CUPs) represent a heterogeneous group of metastatic
tumours for which a standardised diagnostic work-up fails to identify the site of origin at the …
tumours for which a standardised diagnostic work-up fails to identify the site of origin at the …
Comprehensive genomic profiling of carcinoma of unknown primary site: new routes to targeted therapies
JS Ross, K Wang, L Gay, GA Otto, E White… - JAMA …, 2015 - jamanetwork.com
Importance For carcinoma of unknown primary site (CUP), determining the primary tumor
site may be uninformative and often does not improve outcome. Objective To discover …
site may be uninformative and often does not improve outcome. Objective To discover …
Progress in refining the clinical management of cancer of unknown primary in the molecular era
E Rassy, N Pavlidis - Nature reviews Clinical oncology, 2020 - nature.com
Cancer of unknown primary (CUP) is an enigmatic disease entity encompassing
heterogeneous malignancies without a detectable primary tumour, despite a thorough …
heterogeneous malignancies without a detectable primary tumour, despite a thorough …
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches
P Strojan, A Ferlito, JE Medina, JA Woolgar… - Head & …, 2013 - Wiley Online Library
In an era of advanced diagnostics, metastasis to cervical lymph nodes from an occult
primary tumor is a rare clinical entity and accounts for approximately 3% of head and neck …
primary tumor is a rare clinical entity and accounts for approximately 3% of head and neck …
Utility of genomic analysis in circulating tumor DNA from patients with carcinoma of unknown primary
S Kato, N Krishnamurthy, KC Banks, P De, K Williams… - Cancer research, 2017 - AACR
Carcinoma of unknown primary (CUP) is a rare and difficult-to-treat malignancy, the
management of which might be improved by the identification of actionable driver mutations …
management of which might be improved by the identification of actionable driver mutations …
Cancer of unknown primary in the molecular era
S Kato, A Alsafar, V Walavalkar, J Hainsworth… - Trends in cancer, 2021 - cell.com
Cancer of unknown primary (CUP) is a rare malignancy that presents with metastatic
disease and no identifiable site of origin. Most patients have unfavorable features and …
disease and no identifiable site of origin. Most patients have unfavorable features and …
[HTML][HTML] A mini review on cancer of unknown primary site: a clinical puzzle for the oncologists
Cancer of unknown primary (CUP) is a well recognized clinical syndrome, accounting for 3–
5% of all malignancies. It is characterized as a disease with an early dissemination of …
5% of all malignancies. It is characterized as a disease with an early dissemination of …